Fighting MRSA resistance

As reported (here) previously, Israel’s Biomica is developing microbiome therapies for antibiotic resistant bacteria. It is now partnering with the Weizmann Institute to develop a selective treatment against MRSA – antibiotic resistant strains of Staphylococcus aureus infection.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *